| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/23/2007 | CA2381344C Optical system analysis of cells |
| 01/23/2007 | CA2326389C Novel cd19xcd3 specific polypeptides and uses thereof |
| 01/23/2007 | CA2309345C High throughput method for functionally classifying proteins identified using a genomics approach |
| 01/23/2007 | CA2280154C Multiple assays of cell specimens |
| 01/23/2007 | CA2237355C Filtration apparatus and method of characterising molten materials |
| 01/23/2007 | CA2186503C Electrogenerated chemiluminescence labels for analysis and/or referencing |
| 01/23/2007 | CA2158570C Opposable-element chromatographic assay device |
| 01/22/2007 | CA2616526A1 Improved devices and methods for the analysis of biofilm |
| 01/18/2007 | WO2007009125A2 Microfluidic devices and methods of preparing and using the same |
| 01/18/2007 | WO2007008966A1 Elisa to detect multimeric forms of a protein |
| 01/18/2007 | WO2007008882A2 Methods for predicting urine ph |
| 01/18/2007 | WO2007008863A2 Derivatives of di-carbonyl aromachemicals |
| 01/18/2007 | WO2007008759A2 Methods for detecting and confirming minimal disease in a cancer patient |
| 01/18/2007 | WO2007008758A2 Methods for identifying agents and conditions that modulate neurogenesis |
| 01/18/2007 | WO2007008690A2 Methods for monitoring neuroinflammatory destruction of neurons and for treating diseases having an inflammatory component related to phospholipase a2 |
| 01/18/2007 | WO2007008647A2 Diagnosing and grading gliomas using a proteomics approach |
| 01/18/2007 | WO2007008583A2 Improved protein expression comparison assay results and applications |
| 01/18/2007 | WO2007008570A1 Method and apparatus for high altitude environmental data collection |
| 01/18/2007 | WO2007008499A1 Treatment of cancer patients exhibiting activation of the p-glycoprotein efflux pump mechanism |
| 01/18/2007 | WO2007008488A2 Stable quantitation and detection of immune response levels with non-zero background peptides |
| 01/18/2007 | WO2007008252A1 Genetic and epigenetic alterations in the diagnosis and treatment of cancer |
| 01/18/2007 | WO2007008236A2 Methods and apparatus for detecting exposure to hazardous substances |
| 01/18/2007 | WO2007008221A2 DETECTION OF PHOSPHORYLATED eIF2α AS A DIAGNOSTIC TEST FOR EFFICIENCY AND SENSITVITY OF TRANSLATION INITIATION INHIBITORS IN THE TREATMENT OF CANCER AND OTHE R PROLIFERATIVE DISEASES |
| 01/18/2007 | WO2007008158A1 Method for diagnosing multiple sclerosis |
| 01/18/2007 | WO2007008154A1 Method for evaluating the effects of smoke on bronchioles |
| 01/18/2007 | WO2007008092A2 Diagnostic kit for the examination of animal sera for the presence of anti-rhd antibodies and a diagnostic kit for detecting the rhd virus |
| 01/18/2007 | WO2007008084A1 Multicolored particles |
| 01/18/2007 | WO2007008073A2 METHODS FOR DETERMINING THE EFFECT OF A TREATMENT ON THE CROSS-ß STRUCTURE CONTENT OF A PROTEIN; SELECTION OF TREATMENTS AND USES THEREOF |
| 01/18/2007 | WO2007008071A2 Method for detecting peptides comprising a cross-beta structure |
| 01/18/2007 | WO2007008069A2 A method for detecting peptides comprising a cross-b structure |
| 01/18/2007 | WO2007008064A2 Device and method for separating analysing, detecting and/or determining? particles in a liquid sample flow |
| 01/18/2007 | WO2007007849A1 Analyzer and analyzing method |
| 01/18/2007 | WO2007007810A1 Reporter vector for use in evaluation of cyp1a2 induction |
| 01/18/2007 | WO2007007792A1 Detection method and detection kit for antibody |
| 01/18/2007 | WO2007007787A1 Non-human gene-disrupted animal having adam11 gene disruption |
| 01/18/2007 | WO2007007706A1 Method for screening of substance capable of inducing or inhibiting proteinuria, plasmid and transfected cell for use in the method, and biosensor using the plasmid or transfected cell |
| 01/18/2007 | WO2007007519A1 Substance information acquisition method and substance information measurement device using evanescent light, and base arrangement decision method and device |
| 01/18/2007 | WO2007007443A1 Novel polymer and method of measuring cholesterol therewith |
| 01/18/2007 | WO2007007392A1 Novel polymer and method of measuring cholesterol therewith |
| 01/18/2007 | WO2007007327A2 Il-32 modulators |
| 01/18/2007 | WO2007007192A1 Use of ionic matrices for maldi mass spectrometry analysis of tissue sections |
| 01/18/2007 | WO2007007129A2 Diagnostic method for brain damage-related disorders |
| 01/18/2007 | WO2007007116A1 Defensin proteins |
| 01/18/2007 | WO2007007078A2 Measurement method and apparatus for analysing the metal or metal ion conten of a sample |
| 01/18/2007 | WO2007007052A2 Immobilisation of biological molecules |
| 01/18/2007 | WO2007006864A2 Method for evaluating cell populations |
| 01/18/2007 | WO2007006837A1 Co-ordinated control system for lines used for the continuous extraction of virgin olive oil |
| 01/18/2007 | WO2007006581A2 Targeting lsd1 for use in identifying and/or scoring prostate cancer and for controlling anrogen receptor-dependent gene expression |
| 01/18/2007 | WO2007006382A1 Fruit and vegetable quality control device |
| 01/18/2007 | WO2007006180A1 A system for analyzing trace quantity of organic substances in urine and its application |
| 01/18/2007 | WO2007006143A1 Compositions and methods for detecting transformed cells |
| 01/18/2007 | WO2006130535A3 Methods to increase dynamic range and improve quantitative analysis in rapid biosensors |
| 01/18/2007 | WO2006126011A3 Spectral nose |
| 01/18/2007 | WO2006125973A3 Diagnosis of tuberculosis using gene expression marker analysis |
| 01/18/2007 | WO2006125914A3 Use of h11 protein in in vitro diagnosis of streptococcus pyogenes infections |
| 01/18/2007 | WO2006125117A3 Methods for diagnosis and treatment of diseases having an autoimmune and/or inflammatory component |
| 01/18/2007 | WO2006118394A8 System for functional analysis of polypeptides and analysis method for polypeptides |
| 01/18/2007 | WO2006117194A3 Gpr18 as a biomaker for th1 mediated immune response |
| 01/18/2007 | WO2006117193A3 Receptor in dendritic cells |
| 01/18/2007 | WO2006116893A3 Mass spectrometric analysis method |
| 01/18/2007 | WO2006116660A3 Methods of inhibiting a gpr23 |
| 01/18/2007 | WO2006116181A3 Regulatory t cell mediator proteins and uses thereof |
| 01/18/2007 | WO2006116039A3 Method and apparatus for automated rapid immunohistochemistry |
| 01/18/2007 | WO2006113440A3 Multi-transduction mechanism based microfluidic analyte sensors |
| 01/18/2007 | WO2006113237A3 Cd39l3 and its role in diabetes |
| 01/18/2007 | WO2006113220A3 Transgenic mammals expressing human preproinsulin |
| 01/18/2007 | WO2006109086A3 Method to predict the sensitivity of tumors to eg5 inhibitors |
| 01/18/2007 | WO2006107921A3 Lipophilic dye-based fret assays for clostridial toxin activity |
| 01/18/2007 | WO2006105954A3 Use of an antibody against the laminin receptor or laminin receptor precursor for the treatment or diagnosis of several cancer types |
| 01/18/2007 | WO2006105448A3 Proliferation of muc1 expressing cells |
| 01/18/2007 | WO2006099485A3 Compositions and methods for the therapy and diagnosis of kidney cancer |
| 01/18/2007 | WO2006097828A3 Assay for myelosuppression |
| 01/18/2007 | WO2006096780A3 Sirtuin related therapeutics and diagnostics for neurodegenerative diseases |
| 01/18/2007 | WO2006088956A3 Methods of predicting therpeutic response in atopic dermatitis to il-31 antagonists |
| 01/18/2007 | WO2006086098A3 Mass spectrometric methods and products |
| 01/18/2007 | WO2006081473A3 Methods for diagnosis and prognosis of epithelial cancers |
| 01/18/2007 | WO2006079565A3 Leishmania antigens suitable for a diagnostic kit of leishmania |
| 01/18/2007 | WO2006076231A3 Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level |
| 01/18/2007 | WO2006073760A3 Regulation of mink in thymocytes and t lymphocytes |
| 01/18/2007 | WO2006073748A3 Antibodies against antigen presenting cells and uses thereof |
| 01/18/2007 | WO2006073682A3 Diagnostic test |
| 01/18/2007 | WO2006065272A3 Methods for altering acetic acid production and enhancing cell death in bacteria |
| 01/18/2007 | WO2006063182A3 Orthopic reconstituted human breast tumor model in mouse |
| 01/18/2007 | WO2006060839A3 Method for identifying ppt inhibitors |
| 01/18/2007 | WO2006055488A3 Marker for fenestrae |
| 01/18/2007 | WO2006048234A3 Diagnosis and therapy of autophagy-associated diseases |
| 01/18/2007 | WO2006031385A3 Particle separating devices, systems and methods |
| 01/18/2007 | WO2006031378A3 Progesterone receptor structure |
| 01/18/2007 | WO2006031342A3 Paraffin-control marker |
| 01/18/2007 | WO2006031117A8 Lipoxygenase inhibitor peptides and their use |
| 01/18/2007 | WO2005124341A8 Stable isotope labeled polypeptide standards for protein quantitation |
| 01/18/2007 | WO2005102329B1 An innovative screening method for coronary heart disease and stroke |
| 01/18/2007 | WO2005083802A9 Immunoassay reagents and methods of use thereof |
| 01/18/2007 | WO2005081953A3 Conjugated polymer doped nanocomposite silica thin films |
| 01/18/2007 | WO2005079420A3 Chromatographic exclusion agglutination assay and methods of use thereof |
| 01/18/2007 | WO2005042695A3 Lipoparticles comprising proteins, methods of making, and using the same |
| 01/18/2007 | WO2004091383A3 Breast endothelial cell expression patterns |
| 01/18/2007 | WO2004072297A3 Terminal-phosphate-labeled nucleotides and methods of use |
| 01/18/2007 | WO2004054510A3 Method for identifying modulators of human orexin-2 receptor |
| 01/18/2007 | WO2004042348A3 Methods for the identification of inhibitors of chitin synthase 2, s-adenosylmethionine decarboxylase, putrescine aminopropyltransferase, and methylenetetrahydrofolate reductase as antibiotics |